Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved]
With the spread of the novel coronavirus disease of 2019 (COVID-19) worldwide and associated high incidence of thromboembolic complications, the use of heparin is on the rise. It therefore is crucial to identify patients with contraindications for heparin. Heparin-induced thrombocytopenia (HIT) is a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2021-06-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-704/v2 |
| _version_ | 1818657188244094976 |
|---|---|
| author | Ragia Aly Sachin Gupta Sorab Gupta Balraj Singh Abhinav Goyal Sheila Kalathil |
| author_facet | Ragia Aly Sachin Gupta Sorab Gupta Balraj Singh Abhinav Goyal Sheila Kalathil |
| author_sort | Ragia Aly |
| collection | DOAJ |
| description | With the spread of the novel coronavirus disease of 2019 (COVID-19) worldwide and associated high incidence of thromboembolic complications, the use of heparin is on the rise. It therefore is crucial to identify patients with contraindications for heparin. Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of exposure to heparin. We report a 66-year-old woman, who was admitted to the hospital with COVID-19 infection. Her course was complicated by pulmonary embolism and dialysis catheter thrombosis. Our patient had a known history of HIT. Treatment of this patient with heparin would have been catastrophic. The COVID-19 pandemic has overwhelmed healthcare systems and is causing a global health crisis. Nevertheless, this case serves as a reminder of the importance of making every effort to obtain thorough history and review of records of every patient. |
| first_indexed | 2024-12-17T03:37:30Z |
| format | Article |
| id | doaj.art-f455dc3d18e246d09ac0239cef794b7a |
| institution | Directory Open Access Journal |
| issn | 2046-1402 |
| language | English |
| last_indexed | 2024-12-17T03:37:30Z |
| publishDate | 2021-06-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | F1000Research |
| spelling | doaj.art-f455dc3d18e246d09ac0239cef794b7a2022-12-21T22:05:06ZengF1000 Research LtdF1000Research2046-14022021-06-01910.12688/f1000research.24974.257364Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved]Ragia Aly0Sachin Gupta1Sorab Gupta2Balraj Singh3Abhinav Goyal4Sheila Kalathil5Internal Medicine, Danbury Hospital, Danbury, CT, 06810, USAInternal Medicine, Tower Health Reading Hospital, Reading, PA, 19611, USAInternal Medicine, Albert Einstein Healthcare Network, Philadelphia, PA, 19141, USAInternal Medicine, St Joseph Regional Medical Center, Paterson, NJ, 07503, USAInternal Medicine, Albert Einstein Healthcare Network, Philadelphia, PA, 19141, USAInternal Medicine, Albert Einstein Healthcare Network, Philadelphia, PA, 19141, USAWith the spread of the novel coronavirus disease of 2019 (COVID-19) worldwide and associated high incidence of thromboembolic complications, the use of heparin is on the rise. It therefore is crucial to identify patients with contraindications for heparin. Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of exposure to heparin. We report a 66-year-old woman, who was admitted to the hospital with COVID-19 infection. Her course was complicated by pulmonary embolism and dialysis catheter thrombosis. Our patient had a known history of HIT. Treatment of this patient with heparin would have been catastrophic. The COVID-19 pandemic has overwhelmed healthcare systems and is causing a global health crisis. Nevertheless, this case serves as a reminder of the importance of making every effort to obtain thorough history and review of records of every patient.https://f1000research.com/articles/9-704/v2 |
| spellingShingle | Ragia Aly Sachin Gupta Sorab Gupta Balraj Singh Abhinav Goyal Sheila Kalathil Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] F1000Research |
| title | Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] |
| title_full | Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] |
| title_fullStr | Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] |
| title_full_unstemmed | Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] |
| title_short | Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 2; peer review: 2 approved] |
| title_sort | case report heparin induced thrombocytopenia in a patient with covid 19 version 2 peer review 2 approved |
| url | https://f1000research.com/articles/9-704/v2 |
| work_keys_str_mv | AT ragiaaly casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved AT sachingupta casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved AT sorabgupta casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved AT balrajsingh casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved AT abhinavgoyal casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved AT sheilakalathil casereportheparininducedthrombocytopeniainapatientwithcovid19version2peerreview2approved |